ASRV vs CCIF
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ASRV presents a classic deep-value paradox: it is significantly undervalued relative to its Graham Number ($7.43) and Intrinsic Value ($10.03), trading at a low P/B of 0.54. However, the Piotroski F-Score of 3/9 indicates weak fundamental health, suggesting deteriorating operational efficiency or financial stability. While earnings growth is explosive at 74.8% YoY, the low ROE (4.95%) and bearish technical trend (10/100) offset the valuation appeal. The stock is a high-risk value play where the margin of safety is countered by poor health metrics.
CCIF exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9, indicating fundamental weakness across almost all health metrics. The fund is currently paying out dividends at an unsustainable rate with a payout ratio of 420%, which is likely eroding capital. This is compounded by a catastrophic -70% year-over-year decline in EPS and a technical trend of 0/100. Despite a 'strong_buy' analyst consensus, the hard data suggests a value trap characterized by collapsing earnings and a failing price trend.
Compare Another Pair
Related Comparisons
ASRV vs CCIF: Head-to-Head Comparison
This page compares AmeriServ Financial, Inc. (ASRV) and Carlyle Credit Income Fund (CCIF) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.